Supernus Pharmaceuticals Inc (SUPN)
30.55
-0.75
(-2.40%)
USD |
NASDAQ |
May 09, 10:02
Supernus Pharmaceuticals Price: 30.55 for May 9, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 08, 2024 | 30.97 | 31.56 | 30.76 | 31.30 | 461434.0 |
May 07, 2024 | 30.56 | 31.31 | 30.41 | 31.15 | 471705.0 |
May 06, 2024 | 31.04 | 31.40 | 30.14 | 30.42 | 335111.0 |
May 03, 2024 | 30.74 | 30.91 | 30.00 | 30.83 | 362427.0 |
May 02, 2024 | 30.53 | 30.66 | 29.79 | 30.27 | 319381.0 |
May 01, 2024 | 30.15 | 30.69 | 29.99 | 30.08 | 394210.0 |
Apr 30, 2024 | 30.40 | 30.70 | 30.03 | 30.10 | 288562.0 |
Apr 29, 2024 | 30.35 | 31.27 | 30.35 | 30.60 | 365488.0 |
Apr 26, 2024 | 29.46 | 30.19 | 29.17 | 30.07 | 330640.0 |
Apr 25, 2024 | 30.03 | 30.22 | 29.17 | 29.31 | 351464.0 |
Apr 24, 2024 | 29.96 | 30.40 | 29.82 | 30.26 | 201715.0 |
Apr 23, 2024 | 29.75 | 31.84 | 29.59 | 29.95 | 201175.0 |
Apr 22, 2024 | 29.56 | 30.30 | 29.28 | 29.71 | 352474.0 |
Apr 19, 2024 | 28.67 | 29.53 | 28.67 | 29.40 | 361633.0 |
Apr 18, 2024 | 28.87 | 29.48 | 28.63 | 28.87 | 347896.0 |
Apr 17, 2024 | 29.74 | 30.08 | 28.88 | 29.00 | 393830.0 |
Apr 16, 2024 | 30.00 | 30.40 | 29.35 | 29.43 | 388897.0 |
Apr 15, 2024 | 30.51 | 30.60 | 29.68 | 29.99 | 372719.0 |
Apr 12, 2024 | 31.98 | 31.98 | 30.08 | 30.24 | 375040.0 |
Apr 11, 2024 | 32.21 | 32.59 | 31.65 | 32.00 | 454386.0 |
Apr 10, 2024 | 30.97 | 31.92 | 30.74 | 31.84 | 307449.0 |
Apr 09, 2024 | 31.50 | 32.40 | 31.43 | 31.73 | 282392.0 |
Apr 08, 2024 | 30.58 | 33.10 | 30.58 | 31.43 | 789685.0 |
Apr 05, 2024 | 33.33 | 33.60 | 33.13 | 33.55 | 243132.0 |
Apr 04, 2024 | 34.44 | 34.49 | 33.09 | 33.24 | 289968.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
14.45
Minimum
Mar 18 2020
42.03
Maximum
Feb 02 2023
28.75
Average
29.15
Median
Feb 18 2021
Price Benchmarks
Dynavax Technologies Corp | 11.02 |
Ligand Pharmaceuticals Inc | 80.74 |
Pacira BioSciences Inc | 29.96 |
Esperion Therapeutics Inc | 2.155 |
Collegium Pharmaceutical Inc | 38.09 |
Price Related Metrics
PS Ratio | 2.852 |
Price to Book Value | 1.815 |
Price to Free Cash Flow | 15.68 |
Earnings Yield | -0.01% |
Market Cap | 1.672B |
Operating PE Ratio | 129.28 |
Normalized PE Ratio | 114.45 |